5-Amino-1MQ
A small-molecule NNMT inhibitor studied in metabolic and adipose-tissue research models.
Peptide
Browse neutral, educational summaries of published studies and molecular descriptions. Use the calculator for reconstitution math and the research log to record entries against your account.
Research & educational use only
For laboratory and educational research only. Not for human or veterinary consumption. This is not medical advice. Always follow applicable laws and consult qualified professionals.
The calculator performs unit math for research reference. It must not be used to plan or guide dosing in humans or animals. Verify all figures independently in your lab protocol.
Master catalog: 65/65 peptides included
59 individuals · 6 pre-mixed blends — full checklist with detail pages
65 of 65 entries
A small-molecule NNMT inhibitor studied in metabolic and adipose-tissue research models.
A myostatin-pathway modulator studied in muscle-mass and strength research.
A modified Semax analog studied in neuroprotection and cognition research.
A peptidomimetic studied in preclinical models of white adipose tissue targeting.
A copper-binding tripeptide studied in hair follicle and skin research.
An AMPK-activating nucleoside analog studied in exercise-mimetic research.
A fragment of human growth hormone studied in lipid-metabolism research.
An EPO-derived peptide studied in neuropathic pain and tissue-protection research.
A synthetic peptide studied in preclinical models for tissue and gut research.
A long-acting amylin analog studied in obesity and metabolic research.
A short bioregulator peptide studied in cartilage and connective-tissue research.
A neuropeptide mixture studied in stroke recovery and neurodegeneration research.
A GHRH analog with DAC modification studied for extended GH-release kinetics.
A GHRH analog without DAC studied in growth-hormone secretion research.
A hepatocyte growth factor mimetic studied in synaptogenesis and memory research.
A neuropeptide studied in sleep architecture and stress-response research.
A GLP-1 receptor agonist studied in type 2 diabetes and weight-management research.
A tetrapeptide studied in telomere and aging-related research models.
A D-retro-inverso peptide studied in senescent-cell clearance research models.
A follistatin isoform studied in myostatin inhibition and muscle-growth research.
A copper-binding tripeptide studied in skin and tissue research.
A growth-hormone-releasing peptide studied in GH secretagogue research.
A GH secretagogue peptide studied in endocrine and appetite research.
A gonadotropin-releasing hormone analog studied in reproductive endocrine research.
A glycoprotein hormone studied in fertility and endocrine research.
A GH secretagogue hexapeptide studied in cardiac and endocrine research.
Recombinant growth hormone studied in GH-deficiency and body-composition research.
A C-terminal hGH fragment studied in fat-metabolism research models.
A gonadotropin mixture studied in fertility and ovarian-stimulation research.
A modified insulin-like growth factor studied in muscle and metabolic research.
A growth-hormone-secretagogue peptide used in endocrine research.
A neuropeptide fragment studied in reproductive endocrine research.
An alpha-MSH tripeptide fragment studied in anti-inflammatory research.
A GLP-1 receptor agonist studied in diabetes and obesity research.
An antimicrobial host-defense peptide studied in immune and wound-healing research.
A melanocortin receptor agonist studied in photoprotection research.
A melanocortin agonist studied in pigmentation and central receptor research.
A mitochondrial-derived peptide studied in metabolic regulation research.
A coenzyme studied in cellular energy, aging, and NAD-biosynthesis research.
A neuropeptide hormone studied in social bonding and labor-research models.
A TREK-1 channel modulator studied in antidepressant-mechanism research.
A pegylated IGF-1 splice variant studied in muscle-repair research.
A short bioregulator peptide studied in pineal and circadian research.
A melanocortin receptor agonist studied in central nervous system research.
A GIP/GLP-1/glucagon triple agonist studied in obesity research.
A synthetic analog of tuftsin studied in anxiety and cognition research.
A GLP-1 receptor agonist studied in diabetes and weight-management research.
An ACTH-fragment peptide studied in neuroprotection research.
A GHRH fragment studied in growth-hormone stimulation research.
A synthetic octapeptide studied in neuromuscular and cosmetic research.
A mitochondria-targeted peptide studied in oxidative-stress research.
A GLP-1/glucagon dual agonist studied in obesity and NASH research.
Studied in preclinical models related to cell migration and tissue repair.
A GHRH analog studied in lipodystrophy and GH-axis research.
A thymic peptide complex studied in immune-modulation research.
A thymic peptide studied in immune-response and antiviral research.
A GIP/GLP-1 dual agonist studied in diabetes and obesity research.
A GnRH agonist studied in prostate and reproductive endocrine research.
A neuropeptide studied in inflammation, motility, and circadian research.
A pre-mixed recovery blend combining BPC-157 and TB-500 for tissue-research protocols.
A GH-axis blend pairing CJC-1295 (no DAC) with Ipamorelin in endocrine research.
A three-peptide blend (TB-500, BPC-157, GHK-Cu) used in skin and recovery research.
A four-peptide blend (BPC-157, GHK-Cu, TB-500, KPV) for recovery and skin research.
A cognitive blend combining Semax and Selank in neuroprotection research.
A GH-axis blend pairing Tesamorelin with Ipamorelin in metabolic research.